ADACT awarded controlled drugs license for analysing and testing CBD
We’re delighted to announce that ADACT Medical has been granted
The ADACT team are proud to announce that on 9 April 2021 our laboratory received ISO/IEC 17025:2017 accreditation.
Following a lengthly period of assessment, Perry Johnson Laboratory Accreditation, Inc. has awarded the accreditation which demonstrates our technical excellence in the Chemical Testing of e-liquids and e-devices and measuring Harmful and Potentially Harmful Constituents (HPHCs).
ADACT’s Chief Regulatory Officer, Damien Bové, said “The new ISO accreditation is a huge achievement for our laboratory team and comes after huge investment in our vaping and electronic cigarettes testing capabilities over recent months. Going forward, ADACT customers will know their testing is being done to an internationally recognised standard of laboratory excellence which takes into account competence, impartiality and consistent operations.”
To find our how ADACT’s testing capabilities can support your vaping or electronic cigarette brand, please call ADACT on +44(0)1302 986 088 or email hello@adactmedical.com.
We’re delighted to announce that ADACT Medical has been granted
The Decree of 7 March 2022 published in the Official
With the increased scrutiny on disposable products from Trading Standards,
Despite being seen as a ’smokefree success’ after a 2017
We’re delighted to announce that ADACT Medical has been granted a controlled drugs
The Decree of 7 March 2022 published in the Official Gazette introduced in
With the increased scrutiny on disposable products from Trading Standards, regulators and the
